Gynecologic Cancer

Top Story

Chronic pain inhibits daily life for 1 in 6 cancer survivors

June 20, 2019
FDA News

FDA grants fast track designation to TRQ-1501 T-cell therapy for solid tumors, lymphoma

June 18, 2019
The FDA granted fast track designation to TRQ-1501, a deep-primed IL-15 T-cell immunotherapy for the treatment of relapsed or refractory solid tumors and lymphomas that…
Meeting NewsPerspective

MIW815 plus spartalizumab safe, active among certain patients with advanced breast cancer, melanoma

June 17, 2019
CHICAGO — Patients with anti-PD-1-naive triple-negative breast cancer and PD-1-relapsed or refractory melanoma demonstrated antitumor benefit from MIW815 plus…
In the JournalsPerspective

Chemoradiotherapy fails to improve outcomes for advanced endometrial cancer

June 12, 2019
The addition of radiation to platinum-based chemotherapy did not improve RFS among women with stage III or IVA endometrial cancer, according to results of a randomized…
More Headlines »
CME CNE

Focus on Advancing Treatment for Acute Myeloid Leukemia

This activity is supported by an independent educational grant from Pfizer, Inc.

In this activity, Bruno Medieros, MD, and Farhad Ravandi-Kashini, MD, discuss recent advances in the treatment of acute…
More »
Video
Meeting News

VIDEO: Lenvatinib-pembrolizumab shows promise in several cancer types

June 22, 2018
More »
CME

Updates in Genomic Testing for Breast Cancer: Rapid Response From Chicago

This activity is supported by an educational grant from Biotheranostics, Inc.

Multigene assays that evaluate an array of prognostic and/or predictive molecular markers have become critical for the…
More »